Doctors map eye damage from powerful melanoma drugs
NCT ID NCT07427953
Summary
This study aimed to understand a specific eye side effect that can occur when people with melanoma take a common type of targeted drug therapy (BRAF/MEK inhibitors). Researchers closely monitored 14 patients' eyes during and after their cancer treatment to see how the retina changed. The goal was to learn how to better spot, track, and manage this side effect in future patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institute of Oncology Ljubljana
Ljubljana, 1000, Slovenia
Conditions
Explore the condition pages connected to this study.